The Latest in AML

Improving survival in older AML patients

April 26, 2018

AML

Checkpoint inhibition after HiDAC shows promise in AML

April 18, 2018

AML

5- and 10-day decitabine go head-to-head in poor-risk AML

April 18, 2018

AML

Statin plus chemo yields encouraging results in poor-risk AML

April 17, 2018

AML

MRD may indicate relapse risk in AML

April 2, 2018

AML

A global snapshot of leukemia incidence

March 13, 2018

MEC plus ixazomib looks promising in relapsed/refractory AML

March 8, 2018

AML

GCLAM therapy shows promise for relapsed/refractory AML

March 6, 2018

AML

FDA grants priority review for AML drug

February 20, 2018

AML

Tamibarotene shows strong results in high-risk APL patients

February 20, 2018

AML

AML immune profiles correlate with relapse-free survival

February 4, 2018

AML

mIDH inhibitors could fill treatment gap in AML

January 25, 2018

AML

RELAZA2: MRD-guided azacitidine reduces relapse risk in MDS and AML

January 21, 2018

Novel JAK1 inhibitor shows promise for myeloid malignancies

January 18, 2018

FDA approves injection treatment for low-risk APL

January 17, 2018

AML